Inventor · disambiguated record
Si Li
Also filed as: LI SI · Li si-shen
2 granted patents·8 pending applications·0 citations·filing 2009–2024
21Inventor score
Files withGUANGDONG TCRCURE BIOPHARMA TECH CO LTD3TCRCURE BIOPHARMA CORP3HITGEN INC2UNIV NAT TAIWAN1UNIV SOUTHERN CALIFORNIA1
Top patents by PatentIndex Score
10 records- 0173US2025243293A1Combinational tcr-t cell therapy targeting tumor antigens, tgf-beta, and immune checkpointsGUANGDONG TCRCURE BIOPHARMA TECH CO LTD·Filed 2024·Application pending·0 cites
- 0261US2021369776A1Combinational tcr-t cell therapy targeting tumor antigens, tgf-beta, and immune checkpointsGUANGDONG TCRCURE BIOPHARMA TECH CO LTD·Filed 2019·Application pending·0 cites
- 0351US2023227527A1Tcr-t cell therapy targeting epstein-barr virusGUANGDONG TCRCURE BIOPHARMA TECH CO LTD·Filed 2021·Application pending·0 cites
- 0446US11078161B2Rock-inhibiting compound and uses thereofHITGEN INC·Filed 2019·Granted Aug 3, 2021·0 cites·9 claims
- 0545US2021095029A1Compositions and methods for treating cancerUNIV SOUTHERN CALIFORNIA·Filed 2018·Application pending·0 cites
- 0643US2023077100A1Anti-hpv t cell receptors and engineered cellsTCRCURE BIOPHARMA CORP·Filed 2021·Application pending·0 cites
- 0742US12404331B2Anti-PD-1 antibodies and uses thereofTCRCURE BIOPHARMA CORP·Filed 2020·Granted Sep 2, 2025·0 cites·28 claims
- 0842US2011014708A1Nucleic acid for use in algae and use thereofUNIV NAT TAIWAN·Filed 2009·Application pending·0 cites
- 0940US2022119379A1ImmunomodulatorHITGEN INC·Filed 2020·Application pending·0 cites
- 1036US2020046769A1Dual function engineered t cells with hpv e6 specificity and pd-1 blockadeTCRCURE BIOPHARMA CORP·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Si Li files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →